NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Motion
Acquisition Corp. ("Motion") (Nasdaq: MOTN), a special purpose
acquisition company, and its merger partner Ambulnz, Inc., dba
DocGo, a leading provider of Mobile Health services and integrated
medical mobility solutions, announced today that DocGo has
disclosed select preliminary unaudited financial results for its
third quarter ended September 30,
2021.
"We are pleased to report another strong quarter of
positive business momentum highlighted by 201% revenue growth,
positive net income and positive Adjusted
EBITDA1," said Stan
Vashovsky, CEO of DocGo. "We continue to see increasing
demand for our high quality, highly affordable Mobile Health
services as we continue to deliver exceptional patient care and
value across medical mobility and mobile health to generate
sustainable, long-term growth. We are increasing our
full year 2021 revenue outlook to $260
million as a result."
Preliminary Third Quarter Financial Highlights and Increased
2021 Full-Year Revenue Outlook
- On a preliminary basis, total revenue was $81 million in the third quarter of 2021,
representing all-time record quarterly revenue for the sixth
consecutive quarter for DocGo, and a 201% increase from
$26.9 million in the third quarter of
2020.
- Results were aided by the inclusion of revenues from several
large new and expanded Mobile Health contracts.
- Mobile Health revenue increased to approximately $60.6 million in the third quarter of 2021,
compared to $11.4 million in the
prior-year period. Medical mobility revenue was approximately
$20.4 million, up 32% from
$15.5 million in Q3 of 2020.
- DocGo's net income was $0.6
million in the third quarter of 2021, which represents a
substantial improvement over the net loss of $2.7 million in the third quarter of last year.
Adjusted EBITDA1 grew to approximately $3.5 million in the third quarter of 2021 even
with significant investments made in regional expansion and
personnel, versus an Adjusted EBITDA1 loss of
$0.9 million in the prior-year
period.
- Excluding COVID-related testing from both periods, revenue in
the third quarter of 2021 more than tripled year-over-year, when
compared to the results of the third quarter of 2020, with ongoing
positive momentum in the core business.
- As a result of earlier investments in sustainable long-term
opportunities and overall positive business trends expected for the
balance of the year, DocGo is raising its outlook for full-year
2021 revenue to $260 million,
compared to its prior increased outlook for 2021 revenue of at
least $170 million. The company is
also increasing its prior full-year 2021 Adjusted
EBITDA1 guidance from $6
million, to $10 million, even
while planning for continued investments in future growth.
1 Adjusted EBITDA is a non-GAAP measure.
See "Non-GAAP Measure" at the end of this release for a discussion
of this measure, including certain limitations thereof, and a
reconciliation to net income (loss), the most directly comparable
GAAP measure.
Recent Business Highlights
- Launched medical transport services in London to service NHS partners.
- Launched Mobile Health services in Maryland and Michigan.
- Partnered with NYC Health + Hospitals to launch one of the
largest public flu testing programs in the U.S. using DocGo's
Mobile Health units.
- To meet the growing demand for services, hired 780 new
employees in Q3 2021, bringing total hires for the year to 1,741,
and total number of medical providers to over 3,500.
- Announced plans to establish a National Sales Team and hire 20
top-performing industry sales executives to further accelerate
business growth and continue building on the proven success of
DocGo's Mobile Health model.
"Today's preliminary third quarter results and raised outlook
for 2021 further validate the compelling opportunity DocGo
represents for investors," commented Michael Burdiek, Chief Executive Officer of
Motion. "There are very few businesses that successfully reach
scale and experience ongoing triple digit growth, and DocGo is one
of the rare few. The disciplined investments that the company
has made over the last year are really starting to pay dividends
through sustainable, long-term opportunities as evidenced by the
revised full year outlook. We look forward to supporting Stan and
the entire DocGo team as we move through the process towards a
near-term public listing for DocGo."
The foregoing unaudited preliminary financial results represent
the most current information available to DocGo and are based on
calculations or figures prepared internally that have not yet been
reviewed by DocGo's independent registered public accounting firm.
Actual third quarter and year-to-date financial results may
be materially different from the preliminary results described
above and are subject to the risk factors and uncertainties
identified in this press release and in the filings with the
Securities and Exchange Commission (SEC) made by Motion and
DocGo.
About DocGo
DocGo is a leading provider of last-mile
Mobile Health services and integrated medical mobility solutions.
DocGo is disrupting the traditional four-wall healthcare system by
providing care at the scale of humanity. DocGo's innovative
technology and dedicated field staff of certified health
professionals elevate the quality of patient care and drive
business efficiencies for facilities, hospital networks and health
insurance providers. With Mobile Health, DocGo empowers the full
promise and potential of telehealth by facilitating healthcare
treatment, in tandem with a remote physician, in the comfort of a
patient's home or workplace. Together with DocGo's integrated
Ambulnz medical transport services, DocGo is bridging the gap
between physical and virtual care. Upon closing of the
proposed business combination between DocGo and Motion Acquisition
Corp. (Nasdaq: MOTN), the combined company will operate under the
DocGo name and will be listed on Nasdaq under the new ticker symbol
"DCGO". For more information, please visit www.docgo.com.
About Motion Acquisition Corp.
Motion Acquisition
Corp. is a special purpose acquisition company (SPAC) founded by a
management team and board comprised of seasoned business executives
recognized as pioneers in the transportation software and
technology sector that possess substantial operating and
acquisition experience. Motion is listed on Nasdaq under the ticker
symbol "MOTN." For more information, please visit
https://motionacquisition.com/.
Cautionary Statement Regarding Preliminary Estimated
Results
The financial results for DocGo's third quarter
ended September 30, 2021 are
preliminary, unaudited and subject to finalization. They reflect
DocGo management's current views and may change as a result of
DocGo's further review of results and other factors, including a
wide variety of significant business, economic and competitive
risks and uncertainties. Such preliminary results should not be
viewed as a substitute for full quarterly financial statements and
accompanying footnotes prepared in accordance with GAAP.
Motion and DocGo caution you that these preliminary results are not
guarantees of future performance or outcomes, and that actual
results may differ materially from those described above. For more
information regarding factors that could cause actual results to
differ from those described above, please see "Cautionary Statement
Regarding Forward-Looking Statements" below.
The preliminary third quarter financial results have been
prepared by, and are the responsibility of, DocGo's management.
DocGo's independent registered public accounting firm has not
audited, reviewed, compiled, or applied agreed-upon procedures with
respect to the preliminary estimated financial information, and
does not express an opinion or any other form of assurance with
respect thereto.
Cautionary Statement Regarding Forward-Looking
Statements
This announcement contains forward-looking
statements (including within the meaning of Section 21E of the U.S.
Securities Exchange Act of 1934, as amended, and Section 27A of the
U.S. Securities Act of 1933, as amended) concerning DocGo. These
statements include, but are not limited to, statements that address
our expected future business and financial performance and
statements about (i) our plans, objectives and intentions with
respect to future operations, services and products, (ii) our
competitive position and opportunities, and (iii) other statements
identified by words such as "may", "will", "expect", "intend",
"plan", "potential", "believe", "seek", "could", "estimate",
"judgment", "targeting", "should", "anticipate", "predict"
"project", "aim", "goal", "outlook", "guidance", and similar words,
phrases or expressions. These forward-looking statements are based
on management's current expectations and beliefs, as well as
assumptions made by, and information currently available to,
management, and current market trends and conditions.
Forward-looking statements inherently involve risks and
uncertainties, many of which are beyond our control, and which may
cause actual results to differ materially from those contained in
our forward-looking statements. Accordingly, you should not
place undue reliance on such statements. Particular uncertainties
that could materially affect current or future results include, but
are not limited to: possible accounting adjustments made in the
process of finalizing reported financial results; any risks
associated with global economic conditions and concerns; the
effects of global outbreaks of pandemics or contagious diseases or
fear of such outbreaks, such as the COVID-19 coronavirus pandemic;
competitive pressures; pricing declines; rates of growth in our
target markets; our ability to improve gross margins;
cost-containment measures; legislative and regulatory actions; the
impact of legal proceedings and compliance risks; the impact on our
business and reputation in the event of information technology
system failures, network disruptions, cyber-attacks, or losses or
unauthorized access to, or release of, confidential
information; the ability of the company to comply with laws
and regulations regarding data privacy and protection; and certain
other risks and uncertainties identified and discussed in the
sections entitled "Risk Factors" and "Forward-Looking Statement;
Market, Ranking and Other Industry Data" within Motion's definitive
proxy statement/consent solicitation/prospectus filed with the SEC
on October 7, 2021. We undertake
no intent or obligation to publicly update or revise any of
these forward-looking statements, whether as a result of new
information, future events or otherwise.
Additional Information and Where to Find It
This press
release relates to a proposed business combination between DocGo
and Motion, as further described in that certain definitive proxy
statement/consent solicitation/prospectus filed with the SEC on
October 14, 2021, and certain related
documents, to be used at the meeting of Motion stockholders to
approve the proposed business combination and related
matters. Investors and security holders of Motion are urged
to read the definitive proxy statement/consent
solicitation/prospectus, accompanying registration statement, and
any amendments thereto, and all other relevant documents filed or
that will be filed with the SEC in connection with the proposed
business combination as they become available because they will
contain important information about DocGo, Motion, and the proposed
business combination. The definitive proxy
statement/consent solicitation/ prospectus will be mailed to Motion
stockholders of record as of September 9,
2021. Investors and security holders are able to obtain free
copies of the registration statement, the definitive proxy
statement/consent solicitation/prospectus and all other relevant
documents filed or that will be filed with the SEC by Motion, once
such documents are filed, through the website maintained by the SEC
at www.sec.gov.
The documents filed by Motion with the SEC also may be obtained
free of charge at Motion's website
at https://motionacquisition.com or upon written request to
Motion's counsel, Graubard Miller, 405 Lexington Avenue,
New York, NY 10174. The
information contained on, or that may be accessed through, the
websites referenced in this press release is not incorporated by
reference into, and is not a part of, this press release.
Participants in Solicitation
Motion, DocGo, and
certain of their respective directors and executive officers, under
SEC rules, may be deemed to be participants in the eventual
solicitation of proxies from Motion's stockholders in connection
with the proposed business combination. A list of the names of such
directors and executive officers and information regarding their
interests in the proposed business combination are contained in the
definitive proxy statement/prospectus. You may obtain free copies
of these documents as described in the preceding paragraph.
No Offer or Solicitation
This press release shall not
constitute a solicitation of a proxy, consent or authorization with
respect to any securities or in respect of the proposed business
combination. This press release also shall not constitute an offer
to sell or the solicitation of an offer to buy any securities, nor
shall there be any sale of any securities in any state or
jurisdiction in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the
securities laws of such other jurisdiction. No offering of
securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act of 1933, as
amended.
Non-GAAP Financial Measure
"GAAP" refers to financial
information presented in accordance with U.S. Generally Accepted
Accounting Principles. This announcement includes Adjusted EBITDA,
a measure calculated other than in accordance with GAAP. This
non-GAAP financial measure is provided in addition to, and not as a
substitute for, measures of financial performance prepared in
accordance with GAAP. DocGo defines Adjusted EBITDA as
earnings before investment income, interest expense, taxes,
depreciation, amortization, stock-based compensation, litigation
provisions and merger-related expenses. Internally, this
non-GAAP measure is used by management for purposes of evaluating
DocGo's core operating performance, establishing internal budgets,
calculating return on investment for development programs and
growth initiatives, comparing performance with internal forecasts,
strategic planning, evaluating and valuing potential acquisition
candidates, and benchmarking performance externally against
competitors. DocGo believes this non-GAAP financial information
provides additional insight into our financial performance and
future prospects of the company's core business and have therefore
chosen to provide this information to investors to help them
evaluate our results of operations and enhance the ability to make
period-to-period comparisons. Other companies, including companies
in our industry, may not use Adjusted EBITDA or may calculate it
differently than as presented below, limiting Its usefulness as a
comparative measure. In evaluating these non-GAAP measures, you
should be aware that in the future we will incur expenses that are
the same as or similar to some of the adjustments made in the
calculations of Adjusted EBITDA and our presentation of it herein
should not be construed to mean that our future results will be
unaffected by such adjustments.
DocGo does not provide a reconciliation of forward-looking
Adjusted EBITDA guidance to net income, the most directly
comparable GAAP measure, because the impact and timing of certain
of the adjustments cannot be determined without unreasonable
efforts due to their inherent variability, complexity, and
unpredictability. These items, which are necessary for a
presentation of a reconciliation to net income, could have a
potentially significant impact on DocGo's GAAP results.
Reconciliation of Net Income to Adjusted EBITDA
(in $
millions)
|
|
Three months ended
Sept 30
|
|
|
2020
|
|
2021
|
Net Income/(Loss)
(GAAP)
|
|
$
(2.7)
|
|
$
0.6
|
(+) Net interest
expense/(income)
|
|
$
0.1
|
|
$
0.3
|
(+) Income
tax
|
|
$
0.1
|
|
$
0.3
|
(+) Depreciation
& amortization
|
|
$
1.4
|
|
$
2.0
|
EBITDA
|
|
$
(1.1)
|
|
$
3.1
|
(+) Non-cash stock
compensation
|
|
$
0.2
|
|
$
0.4
|
(+) Non-recurring
expense
|
|
$
-
|
|
$
-
|
Adjusted
EBITDA
|
|
$
(0.9)
|
|
$
3.5
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/motion-acquisition-corp-and-docgo-announce-docgos-record-preliminary-third-quarter-2021-revenue-301400712.html
SOURCE DocGo